trending Market Intelligence /marketintelligence/en/news-insights/trending/3hTMR8ILjrCj2vyWB7cWAQ2 content esgSubNav
In This List

GeneNews launches test for breast cancer risk assessment

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


GeneNews launches test for breast cancer risk assessment

GeneNews Ltd. launched BreastSentry, a blood-based biomarker test to assess risk of breast cancer.

The test, launched via the company's Virginia clinical reference lab Innovative Diagnostics Laboratory, measures the fasting plasma levels of two blood biomarkers which are "highly predictive" of the risk for developing breast cancer, GeneNews said.

The test is intended for use by women who are at average risk and have no family of history of breast cancer. The company said BreastSentry is especially suited for the 50% of U.S. women with dense breast tissue, who cannot rely solely on mammography to detect whether they have breast cancer.